Gen Sight Biologics Appoints Laurence Rodriguez As Chief Executive Officer
Dec 22, 2023•over 1 year ago
Position
Chief Executive Officer
Company
GenSight Biologics
Description
GenSight Biologics , a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced today the appointment of Mrs. Laurence Rodriguez, as new Chief Executive Officer.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months